Evidence map›Paper›PMID 30210915›Full record

ArticleAmerican journal of cancer research2018

Prognosis of FTC compared to PTC and FVPTC: findings based on SEER database using propensity score matching analysis.

Zeming Liu, Wen Zeng, Lei Huang, Zhaoyuan Wang, Min Wang, Ling Zhou, Danyang Chen, Haifeng Feng, Wei Zhou, Liang Guo

Abstract read
In one paragraph

Article in American journal of cancer research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zeming LiuDepartment of Plastic Surgery, Zhongnan Hospital of Wuhan University Wuhan 430071, Hubei Province, China.
Wen ZengDepartment of Ophthalmology, Zhongnan Hospital of Wuhan University Wuhan 430071, Hubei Province, China.
Lei HuangDepartment of Plastic Surgery, Zhongnan Hospital of Wuhan University Wuhan 430071, Hubei Province, China.
Zhaoyuan WangDepartment of Plastic Surgery, Zhongnan Hospital of Wuhan University Wuhan 430071, Hubei Province, China.
Min WangDepartment of Plastic Surgery, Zhongnan Hospital of Wuhan University Wuhan 430071, Hubei Province, China.
Ling ZhouDepartment of Plastic Surgery, Zhongnan Hospital of Wuhan University Wuhan 430071, Hubei Province, China.
Danyang ChenDepartment of Plastic Surgery, Zhongnan Hospital of Wuhan University Wuhan 430071, Hubei Province, China.
Haifeng FengDepartment of Plastic Surgery, Zhongnan Hospital of Wuhan University Wuhan 430071, Hubei Province, China.
Wei ZhouDepartment of Plastic Surgery, Zhongnan Hospital of Wuhan University Wuhan 430071, Hubei Province, China.
Liang GuoDepartment of Plastic Surgery, Zhongnan Hospital of Wuhan University Wuhan 430071, Hubei Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The significance of prognosis of follicular thyroid cancer (FTC) compared to other subtypes of thyroid cancer, based on large cohort data has only been addressed in a few studies, and the results remain controversial. In this study, we investigated the prognosis of FTC compared to papillary thyroid carcinoma (PTC) and follicular variant PTC (FVPTC) based on Surveillance, Epidemiology, and End Results database (SEER) Program data using propensity score matching. We evaluated data from 128,703 patients with thyroid cancer who were included in the SEER database between 2004 and 2013. Patient mortality was evaluated using Cox proportional hazards regression analyses and Kaplan-Meier analyses with log-rank tests. The average prognosis of FTC was poorer than both PTC and FVPTC. The multivariate Cox regression analysis revealed that the cancer-specific survival rate for FTC was lower than that for PTC and FVPTC without adjusting for risk factors. Furthermore, after propensity score matching analysis for relevant factors, the cancer-specific mortality rate for FTC was higher than that for PTC and FVPTC. These results based on a large population cohort database provide a benefit reference for individual and precise treatment and management of patients with FTC.

Indexed as

cancer-specific survivalfollicular thyroid cancerPrognosispropensity score matchingSEER

Identifiers

PMID30210915
PMCPMC6129489

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.